Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alana J. De Luca"'
Publikováno v:
Current Oncology Reports. 23
Immune checkpoint immunotherapies (ICI) are now approved for over 20 types of cancer and there are almost 6000 ongoing clinical trials investigating immuno-modulators as cancer therapies. This review investigated the effect of monoclonal antibody-bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b34a1ac1cd7770a7f9c4150c73d9533
https://doi.org/10.1007/s11912-021-01095-x
https://doi.org/10.1007/s11912-021-01095-x
Publikováno v:
Current oncology reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 23(9)
Immune checkpoint immunotherapies (ICI) are now approved for over 20 types of cancer and there are almost 6000 ongoing clinical trials investigating immuno-modulators as cancer therapies. This review investigated the effect of monoclonal antibody-bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32f091dabfc2ceebc7a27967a6796b9f
https://pubmed.ncbi.nlm.nih.gov/34269916
https://pubmed.ncbi.nlm.nih.gov/34269916
Autor:
Alana J. De Luca, A. Bruce Lyons, Peter R. Murphy, Amanda L. Patchett, Jocelyn M. Darby, Gregory M. Woods, Andrew S. Flies, Terry L. Pinfold, Chrissie E. B. Ong, Patrick R. Lennard
Publikováno v:
Science Advances
A simple cut-and-paste reagent development method applicable to any species reveals checkpoint molecules on transmissible cancers.
Around 40% of humans and Tasmanian devils (Sarcophilus harrisii) develop cancer in their lifetime, compared to les
Around 40% of humans and Tasmanian devils (Sarcophilus harrisii) develop cancer in their lifetime, compared to les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d464bfc77591f11bc818ab98e2706f
http://europepmc.org/articles/PMC7458443
http://europepmc.org/articles/PMC7458443